Skip to main content
. Author manuscript; available in PMC: 2024 Mar 25.
Published in final edited form as: Subst Use Misuse. 2023 Feb 20;58(5):685–697. doi: 10.1080/10826084.2023.2177972

Table 3.

Motivations for buprenorphine diversion in the united States, by category, and total number of articles presenting evidence for each category1.

First author, date Avoid withdrawal symptoms Self-treatment of OUD To get high Management of drug use and effects Unable or difficult to procure drug of choice
Allen & Harocopos, 2016 X X X X
Bazazi et al., 2011 X X X X X
Brown & Altice, 2014 X X
Carlson et al., 2020 X
Carroll et al., 2018 X X X X X
Cicero et al., 2014 X X X X X
Cicero et al., 2018 X X X X X
Daniulaityte et al., 2012 X X X X X
Daniulaityte et al., 2015 X X
Daniulaityte et al., 2019 X X
Genberg et al., 2013 X X X
Gryczynski et al., 2013 X X
Mitchell et. al., 2009 X X X
Kavanaugh & McLean, 2020 X X X X X
McLean & Kavanaugh, 2019 X X
Monico et al., 2015 X X
Monico et al., 2021 X X X
Monte et al., 2009 X X
Schuman-Olivier et al., 2010 X
Silverstein et al., 2019 X X X X
Silverstein et al., 2020 X
Smith et al., 2020 X
Sohler et al., 2013 X X X
Tsui et al., 2018 X X
Walker et al., 2018 X X
Wish et al., 2012 X X
Total number of studies 20 18 13 12 11